Companion diagnostic tests are co-developed with their “companion” therapy and aim to aid medical decision-making by revealing which patients are (and are not) likely to respond well to a particular treatment. They can also be used to monitor a patient’s response to therapy.
The companion diagnostics market is growing rapidly, and this list details five main drivers of the field.
Download this list to find out:
What is a tumor-agnostic therapy?
How can adaptive trial designs help?
What is the “All of Us Research Program”?
What technology is behind companion diagnostic tests?
